|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by (used in) continuing operating activities: | |||||
| Provision for credit losses | |||||
| Depreciation and amortization | |||||
| Share-based compensation expense | |||||
| Deferred taxes | |||||
| Net amortization (accretion) of investment securities premiums and discounts | |||||
| Unrealized (gain) loss on investment securities | |||||
| Impairment loss on debt securities | |||||
| Impairment loss on equity securities | |||||
| Net (gain) loss on sale of investment securities | |||||
| Loss on sale of foreign subsidiaries | |||||
| Unrealized gain on equity method investments | |||||
| Impairment loss on fixed assets and leases | |||||
| Unrealized (gain) loss on derivatives | |||||
| Loss on cash flow hedge derivative terminations | |||||
| Settlement of terminated cash flow hedge derivatives | |||||
| Settlement of terminated fair value hedge derivatives | |||||
| Fair value adjustment on loans held for sale | |||||
| (Gain) loss on sale of loans | |||||
| Fair value adjustment on loans held for investment | |||||
| Net (gain) loss on sale of loans and leases | |||||
| Loss on sale of capital call lines of credit | |||||
| Loss on sale of consumer installment loans | |||||
| Origination and purchases of loans held for sale | |||||
| Proceeds from the sales and repayments of loans held for sale | |||||
| Amortization (accretion) of loan net deferred fees, discounts and premiums | |||||
| Earnings on investment in bank-owned life insurance | |||||
| (Increase) decrease in accrued interest receivable and other assets | |||||
| Increase (decrease) in accrued interest payable and other liabilities | |||||
| Net Cash Provided by (Used in) Operating Activities | |||||
| Cash Flows from Investing Activities | |||||
| Proceeds from maturities, calls and principal repayments of investment securities available for sale | |||||
| Proceeds from maturities, calls and principal repayments of investment securities held to maturity | |||||
| Proceeds from sales of foreign subsidiaries | |||||
| Proceeds from sales of investment securities available for sale | |||||
| Purchases of investment securities available for sale | |||||
| Purchases of investment securities held to maturity | |||||
| Purchases of equity method investments | |||||
| Origination of mortgage finance loans | |||||
| Proceeds from repayments of mortgage finance loans | |||||
| Net (increase) decrease in loans and leases, excluding mortgage finance loans | |||||
| Proceeds from sales of loans and leases | |||||
| Purchases of loans | |||||
| Purchases of bank-owned life insurance | |||||
| Proceeds from bank-owned life insurance | |||||
| Net (purchases of) proceeds from sales of FHLB, Federal Reserve Bank, and other restricted stock | |||||
| Purchases of bank premises and equipment | |||||
| Proceeds from sale of fixed assets | |||||
| Proceeds from sales of other real estate owned | |||||
| Proceeds from sales of leased assets under lessor operating leases | |||||
| Purchases of leased assets under lessor operating leases | |||||
| Net Cash Provided By (Used in) Investing Activities | |||||
| Cash Flows from Financing Activities | |||||
| Net increase (decrease) in deposits | |||||
| Net increase (decrease) in short-term borrowed funds from the FHLB | |||||
| Net increase (decrease) in federal funds purchased | |||||
| Net increase (decrease) in borrowed funds from PPP Liquidity Facility | |||||
| Proceeds from long-term borrowed funds from FHLB and FRB | |||||
| Repayments of long-term borrowed funds from FHLB and FRB | |||||
| Proceeds from issuance of other long-term borrowings | |||||
| Repayments of other borrowings | |||||
| Proceeds from issuance of subordinated long-term debt | |||||
| Redemption of preferred stock | |||||
| Preferred stock dividends paid | |||||
| Purchases of treasury stock | |||||
| Payments of employee taxes withheld from share-based awards | |||||
| Proceeds from issuance of common stock | |||||
| Proceeds from sale of non-controlling interest in BMT | |||||
| Net Cash Provided by (Used in) Financing Activities | |||||
| Net Increase (Decrease) in Cash and Cash Equivalents From Continuing Operations | |||||
| Net cash provided by (used in) operating activities | |||||
| Net Increase (Decrease) in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents – Beginning Balance | |||||
| Cash and Cash Equivalents – Ending Balance | |||||
| Supplementary Cash Flow Information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Noncash Investing and Financing Activities: | |||||
| Transfer of investment securities available for sale to held to maturity | |||||
| Purchases of investment securities held to maturity upon sale of consumer installment loans | |||||
| Distribution of investment in BM Technologies common stock | |||||
| Transfer of loans held for investment to held for sale | |||||
| Transfer of loans held for sale to held for investment | |||||
| Transfer of loans to other real estate owned | |||||
Loading...
